* NantHealth Inc NH.OQ reported a quarterly adjusted loss
of 10 cents per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 8 cents per share.
* Revenue fell 23.5% to $14.36 million from a year ago;
analysts expected $17.00 million.
* NantHealth Inc's reported EPS for the quarter was a loss of 9
cents.
* The mean earnings estimate of analysts had risen by
about 15.8% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* NantHealth Inc shares had risen by 5.0% this quarter and
lost 47.7% so far this year.
* The company reported a quarterly loss of $10.84 million.
* Wall Street's median 12-month price target for NantHealth Inc
is $3.50
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated November 5 at 04:44 p.m.
All figures in US dollars unless otherwise stated